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Abstract 
Introduction 
Various established occupational lung carcinogens are also suspected risk factors for laryngeal 
cancer. However, individual studies are often inadequate in size to investigate this relatively rare 
outcome. Other limitations include imprecise exposure assessment and inadequate adjustment for 
confounders. 
Methods  
This study applied a quantitative job exposure matrix (SYN-JEM) for four established occupational 
lung carcinogens to five case–control studies within the INHANCE Consortium. We used 
occupational histories for 2256 laryngeal cancer cases and 7857 controls recruited from 1989-2007. 
We assigned quantitative exposure levels for asbestos, respirable crystalline silica, chromium-VI, 
and chromium-VI & nickel combined (to address highly correlated exposures) via SYN-JEM. We 
assessed effects of occupational exposure on cancer risk for males (asbestos, respirable crystalline 
silica, chromium-VI, chromium-VI & nickel) and females (asbestos, respirable crystalline silica), 
adjusting for age, study, tobacco smoking, alcohol consumption, and asbestos exposure where 
relevant. 
Results  
Among females, odds ratios (ORs) were increased for ever versus never exposed. Among males, p-
values for linear trend were <0.05 for estimated cumulative exposure (all agents) and <0.05 for 
exposure duration (respirable crystalline silica, chromium-VI, and chromium-VI & nickel); strongest 
associations were for asbestos at >90%ile cumulative exposure (OR=1.3, CI=1.0-1.6), respirable 
crystalline silica at 30+ years duration (OR=1.4, CI=1.2-1.7) and 75%-90%ile cumulative exposure 
(OR=1.4, CI=1.1-1.8), chromium-VI at >75%ile cumulative exposure (OR=1.9, CI=1.2-3.0), and 
chromium-VI & nickel at 20-29 years duration (OR=1.5, CI=1.1-2.2). 
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Conclusions  
These findings support hypotheses of causal links between four lung carcinogens (asbestos, 
respirable crystalline silica, chromium-VI, and nickel) and laryngeal cancer. 
Keywords 
Occupational Exposure, Laryngeal Neoplasms, Case–control Studies, Asbestos, Respirable 
Crystalline Silica, Nickel, Chromium(VI) 
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INTRODUCTION 
An estimated 177,000 people worldwide receive a diagnosis of laryngeal cancer each year (1). 
Smoking and alcohol are presumed to be responsible for a large proportion of these cancers (2); 
asbestos and strong inorganic acid mists are the only other agents with established causal links to 
laryngeal cancer in humans (3,4). A growing body of evidence indicates that other occupational 
exposures may play a role in the development of laryngeal cancer; however, individual studies are 
often inadequate to assess relationships with this relatively rare outcome. Exposure assessment with 
low accuracy is an important limitation in this regard, in addition to small study size and inadequate 
adjustment for potentially strong confounders (i.e., smoking and alcohol consumption) (5). 
Population-based case–control studies can be a useful approach when the outcome of interest, such 
as laryngeal cancer, is rare. Exposure assessment in this context, complicated by participants’ 
employment in a wide variety of occupations and industries, often consists of retrospective 
estimation using some combination of self-reporting, expert judgment, and/or generic job exposure 
matrices (JEMs) to assign exposures in a qualitative or semi-quantitative way (6).  
While detailed exposure monitoring is typically not an option in case–control studies, relevant 
historical measurements can be integrated with occupational hygiene expertise to conduct 
quantitative exposure estimation through modeling. One example is the SYN-JEM (7), a quantitative 
job exposure matrix of established lung carcinogens based on personal measurements from 18 
European countries and Canada. Although originally developed for use in a pooled analysis of lung 
cancer case–control studies (8), SYN-JEM can also be applied to retrospectively estimate 
occupational exposure to these agents for other health outcomes in community-based studies. 
The International Agency for Research on Cancer (IARC)’s Monographs Program has classified 
asbestos, crystalline silica dust, chromium VI compounds, and nickel compounds as Group 1 
(Carcinogenic to humans) (3). These classifications were based in whole or in part on sufficient 
evidence in humans for cancer of the lung. Of these, asbestos is the only agent with sufficient 
AC
CE
PT
ED
Copyright © Wolters Kluwer Health, Inc. All rights reserved. Unauthorized reproduction of this article is prohibited.
9 
 
evidence for a causal link with cancer of the larynx (limited evidence has not yet been established for 
the others, by the IARC classification). Further consideration of these agents as risk factors for 
laryngeal cancer is justified, given their established carcinogenic effects in the lung and common 
route of exposure via inhalation. The current study was conducted to investigate these relationships 
while addressing important quality issues (such as limited exposure assessment, study size, and 
control of confounding) in individual case–control studies of occupational exposure and laryngeal 
cancer.  
METHODS 
Study population 
We drew the study population from the International Head and Neck Cancer Epidemiology 
(INHANCE) Consortium, a global collaboration established in 2004 among research groups 
currently or recently conducting large molecular epidemiologic studies of head and neck cancer (9). 
All studies included in the current analyses were required to have a recruitment protocol for cases 
and controls, as well as a structured questionnaire to collect information on demographic factors, 
occupational history, tumor characteristics, alcohol consumption, and tobacco use. Occupational 
histories consisted of a list of employment periods for each study participant over the course of their 
career, with start and end date as well as job held recorded for each period. Laryngeal cancer cases 
were classified by the original studies as participants with invasive tumors of the larynx (including 
glottis, supraglottis, and subglottis; ICD-10 codes C32.0-C32.3 and C32.8-C32.9) (9). Data were sent 
to the INHANCE Consortium with personal identifiers removed; we then carefully conducted 
harmonization procedures to ensure accuracy and consistency between studies, with all items double-
checked for illogical or missing values and inconsistencies resolved via queries to original study 
investigators (10).  
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To permit linkage with the SYN-JEM, the study sample was restricted to five INHANCE studies 
with occupational histories coded to the International Standard Classification of Occupations 
(ISCO)-68 of the International Labor Organization (11) (2469 laryngeal cancer cases and 8328 
controls). Characteristics of the five case–control studies included in these analyses (after exclusions) 
are provided in eTable 1; http://links.lww.com/EDE/B599. Two were multicenter studies, based in 
Western Europe (12) and Latin America (13), respectively; the others were based in France (2 
studies; (14,15)) and in Germany (1 study; (16)). Most studies were hospital-based; controls were all 
frequency-matched to cases on age, sex, and other factors. Participation rates ranged from 80%-96% 
for cases, and from 62%-86% for controls.  
Ethics approval 
Each INHANCE study obtained investigation approval from its respective institutional review board, 
and informed consent was obtained from every study participant. Approval for the current project 
was obtained from the IARC ethics committee (project 18-02). 
Exposure assessment 
Details on the development of SYN-JEM have been published elsewhere (7). In brief, empirical 
models were developed using individual personal measurements of occupational exposures in a 
range of European countries and Canada, collected between the 1970s and 2009 (17). Only 
measurements with a job code available and a sampling duration between 60 and 600 minutes were 
selected to construct a linear mixed-effects model for each agent (27,958 measurements for asbestos, 
24,150 for chromium (of which 8363 were chromium-VI), 23,640 for respirable crystalline silica, 
and 22,081 for nickel).  
Random effects terms included region/country and job title; fixed effects included measurement 
year, sampling duration, and prior exposure rating that was based on an independent general 
population job exposure matrix (DOM-JEM) that assigned no, low, or high exposure to all ISCO-68 
job titles (18). Additional fixed effects that considered sampling and analytical aspects were selected 
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for each agent as appropriate, such as “chromium type” to normalize all estimates to chromium-VI 
levels, and country-specific year of asbestos ban implementation to indicate whether the 
measurement was taken pre- or post-ban. Model predictions provided an estimated annual geometric 
mean exposure for a given job, region/country, and year for each agent, with asbestos expressed as 
f/ml, and respirable crystalline silica, chromium-VI, and nickel expressed as mg/m3. Agent-specific 
overall linear time trends were applied to all jobs and regions for each agent.  
The quantitative SYN-JEM estimates were linked with individual job periods from INHANCE self-
reported occupational histories at Utrecht University’s Institute for Risk Assessment Sciences. The 
SYN-JEM assesses exposure levels for each job title coded with the ISCO-68 (11). When exposure 
measurements were available, jobs classified as exposed by the DOM-JEM were assigned the job-
specific estimates derived from the prediction model. In situations where there were fewer than five 
measurements for a job title, the job-specific estimate was calculated using the weighted mean of the 
jobs at the 5-digit ISCO-68 code within the same (3-digit) unit or (2-digit) group (19). For jobs 
considered unexposed in DOM-JEM, overrides were applied to SYN-JEM model predictions to 
assign zero exposure.  
In the INHANCE data, over 99% of participants who had ever been estimated as exposed to nickel 
had also been exposed to Chromium-VI, with highly correlated exposure durations and cumulative 
exposures noted between the two agents (r > 0.80). Therefore, we assessed participants exposed to 
chromium-VI only (n = 446; 23% of all chromium-VI exposed participants) separately from 
participants co-exposed to both chromium and nickel. For the chromium-VI & nickel co-exposed 
group, we standardized exposures to each metal to the median exposure of the exposed group by 
dividing the estimated exposure of an individual by the group median for each of the two agents and 
then summing these two values. For example, an individual with 10 mg/m3–years of chromium-VI 
(with group median of 2 mg/m3–years) and 10 mg/m3–years of nickel (with group median of 1 
mg/m3–years), would be assigned a standardized cumulative exposure of 15 unit years. We did this 
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to address the issue of co-exposure while avoiding the assumption that chromium-VI and nickel have 
the same impact on laryngeal cancer odds ratios per mg/m3-year, which would have been implied if 
these exposures were simply summed without standardization. 
Statistical analyses 
We fitted logistic regression models for males and females separately to assess the effects of 
exposure to asbestos, to respirable crystalline silica, to chromium-VI only, and to the combination of 
chromium-VI and nickel on laryngeal cancer. For females, we only assessed exposures to asbestos 
and respirable crystalline silica because of the small numbers of study participants exposed to 
chromium-VI and nickel. 
Never exposed to the agent under evaluation formed the reference category for each analysis. For 
males, we assessed three exposure metrics for each agent: ever occupational exposure, duration of 
exposure (<10, 10-19, 20-29, and ≥30 years), and estimated cumulative exposure (summed over 
participants’ entire work histories). For the cumulative metric, categorical cut-points were based on 
the exposure distribution among control participants: <50th, 50-75th, and >75th percentiles for 
chromium-VI and chromium-VI & nickel, and, where greater numbers of exposed participants were 
available, <50th, 50-75th, 75-90th, and >90th percentiles for asbestos and respirable crystalline silica. 
For females, the same exposure metrics were assessed, although median exposure in controls was 
used as the cut-point for categories of duration and cumulative exposure due to the small numbers of 
exposed participants.  
We adjusted for potential confounders in stages. Model 1 estimates were adjusted for participant age 
and study (to account for differences in individual study time periods and methodologies used; see 
eTable 1; http://links.lww.com/EDE/B599). Model 2 estimates were additionally adjusted for 
tobacco smoking and alcohol consumption, since these are known risk factors for laryngeal cancer 
(2,10) and may be associated with occupational characteristics (20,21). Confounding by smoking is 
often adjusted for using pack–years (10,22–25); however, smoking cessation has also shown a strong 
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negative association with laryngeal cancer, with risk decreasing as time since quitting increases (26). 
Therefore, a categorical variable was created to account for both pack–years and time since quitting 
tobacco smoking in males (see Table 1). For females, we adjusted for tobacco smoking using a 
continuous log-transformed pack–years variable, again due to the small numbers of exposed 
participants. We used a continuous variable to describe the intensity of alcohol in drinks of ethanol 
per day based on cumulative consumption (ml/day/15.6 ml of ethanol). Estimates from model 2 for 
respirable crystalline silica, chromium-VI, and chromium-VI & nickel were additionally adjusted for 
duration of exposure to asbestos, an established carcinogenic agent for laryngeal cancer in humans 
(3).  
We calculated p-values for linear trend for duration and estimated cumulative exposure by applying 
a logistic regression model that included the variable of interest as continuous.  
In addition to the main analyses, we applied exposure lags of 10 and 20 years in the years before 
diagnosis and interview to all agents and metrics. We conducted additional sensitivity analyses for 
the agents with largest numbers of exposed participants (asbestos and respirable crystalline silica). 
The potential effects of selection bias were investigated by limiting the sample to blue-collar workers 
only. We also examined the effects of excluding Latin America from the analyses (since SYN-JEM 
estimates were based on exposure data collected outside of this region).  
RESULTS 
We excluded participants with missing data on sex, age, occupational history, tobacco smoking, and 
alcohol use (213 cases and 471 controls). The resulting baseline analytic sample included 2256 
laryngeal cancer cases (203 females; 2053 males) and 7857 control participants (1604 females; 6253 
males). 
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Table 1 shows study participant characteristics by disease status and sex. For both males and females 
the largest proportions of laryngeal cancer cases were in individuals aged 50-69 and in current 
smokers. For alcohol, the largest proportion of laryngeal cancer cases was in male (but not female) 
heavy drinkers.   
Table 2 summarizes participants’ 50th, 75th, and 90th percentile estimated cumulative exposure 
distributions by case/control status and sex. Exposures were lognormally distributed and typically 
higher for cases compared to control participants, except for exposure to asbestos among females.  
Other than chromium-VI and nickel, exposure correlations between agents were low (r < 0.4 for both 
duration and cumulative exposure). We observed weak correlations between cumulative exposure to 
all agents and tobacco smoking (log-transformed packyears) (r < 0.10), and between all agents and 
cumulative alcohol consumption (r < 0.10). 
Tables 3-5 show odds ratios (ORs) for laryngeal cancer associated with the three exposure metrics 
assessed, for asbestos, respirable crystalline silica, chromium-VI & nickel, and chromium-VI, by two 
levels of adjustment for potential confounding. The addition of asbestos as a potential confounder in 
the models for respirable crystalline silica, chromium-VI & nickel, and chromium-VI produced only 
very small changes in effect estimates. For all agents, ORs were higher for ever exposed versus non-
exposed in both males and females. For other analyses, the strongest associations were observed in 
males for asbestos at >90%ile cumulative exposure (OR=1.3, CI=1.0-1.6), respirable crystalline 
silica at 30+ years duration (OR=1.4, CI=1.2-1.7) and 75%-90%ile cumulative exposure (OR=1.4, 
CI=1.1-1.8), chromium-VI at >75%ile cumulative exposure (OR=1.9, CI=1.2-3.0), and chromium-
VI & nickel at 20-29 years duration (OR=1.5, CI=1.1-2.2). Study-specific results for ever versus 
never exposed males across all four agent categories (eFigures 1-4; http://links.lww.com/EDE/B599) 
indicate some heterogeneity between studies; the direction and strength of individual study effects on 
pooled results varied between agents. 
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Asbestos  
Ever occupational exposure to asbestos occurred for 55% of male cases (55% of controls), and 12% 
of female cases (9% of controls) (Tables 3 and 4). In fully adjusted results for males, the greatest 
increases were observed in the highest categories of exposure duration (p-value for linear trend = 
0.06) and estimated cumulative exposure (p-value for linear trend = 0.04). In fully adjusted results 
for females, ORs were increased for both the low exposure duration (50th %ile cut-off of 5 years) and 
the low cumulative exposure (<50th %ile, or <0.35 f/ml–years) categories.  
Respirable crystalline silica  
Ever occupational exposure to respirable crystalline silica occurred for 41% of male cases (29% of 
controls), and for 19% of female cases (13% of controls) (Tables 3 and 4). In fully adjusted results 
for males, the greatest increases were observed for the highest category of exposure duration (p-
value for linear trend <0.0001) and the 75-90th %ile (or 1.95-3.55 mg/m3–years) category of 
cumulative exposure (p-value for linear trend = 0.0002). In fully adjusted results for females, the 
strongest increases in ORs were observed in the highest categories of exposure duration (≥50th %ile, 
or ≥13 years) and cumulative exposure (≥50th %ile, or ≥0.93 mg/m3–years). 
Chromium-VI and nickel combined 
Exposure to both chromium-VI and nickel in the workplace occurred in participants’ work history 
for 24% of male cases (17% of controls) (Table 5). In fully adjusted results, the greatest increases in 
ORs were observed for the 20-29 years duration category (p-value for linear trend = 0.02) and for the 
highest categories of cumulative exposure (p-value for linear trend = 0.02). The interpretation of 
results obtained after standardizing and summing quantitative exposure estimates for chromium-VI 
and nickel were unchanged compared to when each metal was assessed independently in additional 
analyses, reflecting the high correlation of nickel with chromium-VI exposure.  
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Chromium-VI  
Ever exposure to chromium-VI without exposure to nickel occurred for 10% of male cases and 6% 
of male controls (Table 5). In fully adjusted results, the highest ORs were observed for the 20-29 
years exposure duration category (p-value for linear trend = 0.04) and for the highest category of 
cumulative exposure (p-value for linear trend = 0.0014). 
Additional analyses (males only) 
Results did not differ substantially by exposure lag-times of 10 and 20 years (eTables 2-5; 
http://links.lww.com/EDE/B599). Analyses restricted to include only participants who had ever 
worked in a “blue-collar” job weakened effect estimates for asbestos and respirable crystalline silica 
(eTable 6; http://links.lww.com/EDE/B599). The exclusion of study participants from the Latin 
America study increased the strength of effect estimates in analyses of asbestos and respirable 
crystalline silica, but did not change overall interpretations (eTable 7; 
http://links.lww.com/EDE/B599).  
DISCUSSION 
This study analyzed the risk of laryngeal cancer in relation to occupational exposure to four known 
lung carcinogens (asbestos, respirable crystalline silica, chromium-VI, and chromium-VI & nickel). 
This was done by combining two unique data sources: a new quantitative job exposure matrix 
designed for large community-based human health studies (SYN-JEM), and case–control data with 
complete occupational history and detailed information on tobacco smoking and alcohol 
consumption from five studies within the International Head and Neck Cancer Epidemiology 
(INHANCE) Consortium. We observed increased risks of laryngeal cancer associated with all agents 
evaluated. In males, positive tests for linear trend (p < 0.05) (including unexposed participants) were 
observed for estimated cumulative exposure to all agents, and for duration of exposure to respirable 
crystalline silica, chromium-VI & nickel combined, and chromium-VI. The relationships in males 
were based on a larger number of exposed cases and controls, and results were more robust; 
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interpretation of results in females was limited by the small number of exposed participants (see 
Table 5). For this reason, the following discussion will focus on comparisons of findings in males.  
Asbestos 
Findings from this study are in line with those of other studies of asbestos and laryngeal cancer 
(3,27). A recently conducted meta-analysis of 21 publications noted elevated risks of laryngeal 
cancer mortality with long study follow up (>25 years) (standardized mortality ratio [SMR] 1.70, 
95% CI 1.43-2.02) and in high-exposure cohorts (SMR 2.07, CI 1.54-2.76) (27). A cohort study of 
asbestos miners in Northern Italy observed an increased SMR for laryngeal cancer (SMR 2.67, 95% 
CI 1.15-5.25) (28). It is notable that increased ORs were observed in the current community-based 
analyses despite the relatively low estimated cumulative exposure levels (less than 5 f/ml–years at 
the 90th %ile) compared to those reported in this and other industry-based cohorts (3). 
Respirable crystalline silica 
Few other studies on laryngeal cancer have examined exposure to silica dust quantitatively. In a 
case–control study in Turkey, ever exposure to silica dust showed an increased OR for laryngeal 
cancer (OR 1.5, CI 1.2-1.9) (29). In the same study, an exposure–effect relationship was observed 
with increasing intensity of silica exposure. However, an Uruguay-based study did not observe 
increased ORs for laryngeal cancer with ever exposure to silica dust (OR 0.9, CI 0.6-1.5), nor with 
increasing duration of exposure (1-20 years OR 1.1, CI 0.6-1.9; 21+ years OR 0.8, CI 0.5-1.5) (30).  
A meta-analysis of silica dust and laryngeal cancer observed an increased pooled odds ratio (OR 
1.39, CI 1.17-1.67) of laryngeal cancer in workers exposed to silica dust in six case–control studies 
(includes some assessed in the current pooled analyses) that adjusted for smoking and alcohol 
consumption (31). In their review of 16 cohort studies, the same authors observed only small 
increases in SMRs and standardized incidence ratios related to silica dust exposure and silicosis; a 
clear interpretation of results was limited by lack of adjustment for smoking or alcohol consumption 
(31).  
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Chromium-VI & Nickel and Chromium-VI  
While ORs were increased in the highest categories of cumulative exposure for both the chromium-
VI & nickel and chromium-VI groups, stronger effects were noted in those only exposed to 
chromium-VI. A possible explanation for this difference could relate to the distinct nature of these 
exposures across the two groups. For individuals co-exposed to nickel and chromium-VI, 
approximately 75% held metal working jobs (e.g., welder, metal worker) where exposure to finer 
metal fumes could be expected. For those exposed to chromium-VI but not nickel (e.g., masons, tile-
setters, tanners, painters, etc.), with exposure to coarser aerosols expected, more deposition of 
chromium-VI in the upper respiratory tract, including the larynx, may have occurred. It is also 
possible that these individuals encountered other unmeasured co-exposures. 
Several independent studies have identified occupational exposure to metal dust as a risk factor for 
laryngeal cancer (32–34), although studies assessing quantitative exposure–effect relationships 
between exposure to nickel and chromium-VI and laryngeal cancer could not be located. 
Strengths and limitations 
This study’s quantitative exposure estimates were based on a large number of workplace 
measurements, where modeling incorporated determinants of exposure such as year and region 
(7,17). This level of detail is relatively unique in case–control studies of long-latency diseases. 
Results obtained from analyses of broad metrics (such as industry or occupation) can be useful for a 
number of purposes, such as to inform general intervention, compensation, and research activities; 
however, they cannot identify specific agents as risk factors for cancer (35). In contrast, the current 
study investigated laryngeal cancer risks associated with quantitative estimates of exposure to 
individual agents using full occupational histories, providing a stronger basis to support quantitative 
risk assessment and specific exposure reduction activities.  
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The ability to identify one particular agent as a risk factor for cancer may be impacted by the 
potential for co-exposure to other carcinogenic agents. This study’s large sample size permitted 
separate analyses of participants exposed to chromium-VI but not nickel, compared to those co-
exposed to chromium-VI and nickel. The standardization and addition of chromium-VI & nickel 
exposures in their combined analyses was preferable to assuming equal effects through simple 
addition, although it did not entirely avoid this assumption.  
Final models for respirable crystalline silica and metal agents adjusted for exposure to asbestos, an 
established laryngeal carcinogen. The only other established occupational risk factor for laryngeal 
cancer, strong inorganic acid mists, was not assessed in this study, although limited co-exposure 
would be expected given the main industries where acid mists occur (e.g., manufacturers of 
phosphate fertilizer, isopropyl and ethyl alcohols, sulfuric and nitric acids, and lead batteries (4)). 
Nevertheless, co-exposure to other carcinogenic substances in participants’ work histories cannot be 
ruled out.  
An inherent limitation of job exposure matrices is the potential for exposure misclassification, since 
all individuals in a given job category are assigned the same level of exposure. However, the strategy 
of applying the mean of all exposure measurements within an occupational group offers the benefit 
of a Berkson error structure, in which exposure–effect relationships are not attenuated but come with 
a loss of precision (36). Further, the quantitative job exposure matrix (SYN-JEM) used to develop 
the estimates in our study was based on a database of thousands of personal workplace 
measurements from 19 countries (17). Most of these measurements (77%) were collected in a 
representative manner (i.e., where the aim of sampling is to obtain exposure measurements 
representative of all workers with a given job title), although they were not obtained from the studies 
included in the current pooled analyses. While these personal measurements cover a wide period, 
from the 1970s to 2009, the majority were collected after 1975 (17). Since the job history period for 
INHANCE participants spanned 1915 to 2008, some of the modelled estimates for jobs held prior to 
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1975 may not accurately reflect “true” exposures in earlier time periods. To address potential issues 
with back extrapolation for all SYN-JEM estimates, a constant maximum exposure level was 
assigned to jobs held earlier in the 20th century, to avoid the assignment of unrealistic levels (7).  
Some heterogeneity was noted between the individual studies used in these analyses, with variable 
direction and strength of effects noted across agents. We adjusted for study in the models in an 
attempt to address differences in time periods, geographic locations, and methodologies across 
individual studies. 
Because the SYN-JEM did not include exposure data from Latin America, exposures for these 
participants were applied using regional estimates for Spain and Italy, based on expected similarities 
in working and seasonal conditions between the regions. While this likely introduced some degree of 
exposure misclassification, excluding Latin American study participants from the analyses of 
asbestos and respirable crystalline silica did not change overall interpretations of the effect estimates. 
In addition to its relatively large sample size that increased precision, the INHANCE consortium 
case–control study data provided the benefit of detailed information on tobacco smoking and alcohol 
drinking, which is important to address the strong potential for confounding by these factors in 
analyses of laryngeal cancer. Adjustment for these variables substantially influenced effect estimates 
for asbestos (demonstrated by differences observed between Model 1 and Model 2 adjustments) 
while a lesser change was observed for respirable crystalline silica and metals. Nevertheless, residual 
confounding by misclassification of tobacco smoking and alcohol drinking might have affected the 
observed associations.   
We cannot rule out selection bias in this study. While all studies frequency matched controls to cases 
based on age, sex (where relevant), and regional factors, participation rates for control participants 
(range of 62%-86%) were generally lower than those of cases (range of 82%-96%). We examined 
selection bias by restricting analyses to ever blue-collar workers; effects generally weakened but did 
not differ substantially from main results (eTable 6; http://links.lww.com/EDE/B599).  
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Case–control studies are also generally susceptible to recall bias, which may lead to differential 
exposure misclassification. However, prior studies have not found evidence of recall bias when 
investigating differences in job history reporting validity between cases and controls (37,38). 
Further, validation studies that have assessed self-reported occupational histories against objective 
measures (e.g. company, pension, and union records) have reported generally consistent levels of 
agreement, i.e., between 70-90% (6)).  
Conclusions 
The results of this study support hypotheses of a carcinogenic effect of four lung carcinogens 
(asbestos, respirable crystalline silica, chromium-IV, and chromium-VI with nickel) on laryngeal 
cancer.  
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Table 1: Descriptive characteristics of study participants (2256 laryngeal cancer cases and 7857 control participants), by sex 
 
  MALES  FEMALES 
  
Cases 
n = 2053 
Controls 
n = 6253  
Cases 
n = 203 
Controls 
n = 1604 
Characteristic Category n % n %  n % n % 
Age (years) 
< 50 273 13 1237 20  27 13 330 21 
50-59 700 34 1926 31  68 34 399 25 
60-69 713 35 1989 32  61 30 478 30 
≥ 70 367 18 1101 18  47 23 397 25 
Tobacco smoking 
(pack–years and 
years since quitting)  
Never smoker 76 4 1789 29  28 14 971 61 
< 20 Pack–yrs and 10+ yrs since quit 125 6 1515 24  9 4 199 12 
< 20 Pack–yrs and 1-9 yrs since quit 64 3 222 4  2 1 51 3 
< 20 Pack–yrs and Current smoker 152 7 514 8  31 15 164 10 
21-40 Pack–yrs and 10+ yrs since quit 117 6 492 8  4 2 22 1 
21-40 Pack–yrs and 1-9 yrs since quit 118 6 240 4  8 4 25 2 
21-40 Pack–yrs and Current smoker 427 21 611 10  62 31 108 7 
> 40 Pack–yrs and 10+ yrs since quit 97 5 212 3  1 1 9 1 
> 40 Pack–yrs and 1-9 yrs since quit 161 8 193 3  6 3 18 1 
> 40 Pack–yrs and Current smoker 716 35 465 7  52 26 37 2 
Alcohol drinking 
Never drinker 110 5 484 8  70 35 502 31 
0 < drinks/day < 1 324 16 2201 35  74 37 848 53 
1 ≤ drinks/day < 3 481 23 2013 32  38 19 216 14 
3 ≤ drinks/day < 5  353 17 792 13  11 5 21 1 
≥ 5 drinks/day 785 38 763 12  10 5 17 1 
Study 
France multi-centre (1989-1991) 292 14 272 4  N/A N/A N/A N/A 
France multi-centre (2001-2007) 444 22 2744 44  49 24 744 46 
Germany Heidelberg 207 10 693 11  17 8 65 4 
Latin America 643 31 1119 18  79 39 272 17 
Western Europe 467 23 1425 23  58 29 523 33 
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Table 2: Estimated cumulative exposure distributions of exposed study participants by agent, sex, and case or control status 
 
 
Asbestos  
(Males) 
RCS  
(Males) 
Cr-VI–nickel  
(Males) 
Cr-VI  
(Males) 
Asbestos  
(Females) 
RCS  
(Females) 
  Cases 
n = 1126  
Controls 
n = 3426  
Cases 
n = 833  
Controls 
n = 1813  
Cases 
n = 446  
Controls 
n = 1035  
Cases 
n = 155  
Controls 
n = 285  
Cases 
n = 24 
Controls 
n = 147  
Cases 
n = 38  
Controls 
n = 38  
CUMULATIVE EXPOSURE a             
median 0.98 0.56 1.2 0.88 2.1 2.1 0.011 0.008 0.28 0.35 1.0 0.93 
75%ile 2.3 1.6 2.4 2.0 5.3 5.0 0.020 0.017 - - - - 
90%ile 4.3 3.2 4.0 3.6 - - - - - - - - 
RCS = Respirable crystalline silica; Cr-VI = Chromium-VI 
         
a Cumulative exposure metrics used in all models (Tables 3-5) are based on distributions in exposed control participants; expressed in fibers (f)/ml–
years for asbestos; mg/m3–years for RCS and Cr-VI; unit–years for Cr-VI–nickel 
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Table 3. Laryngeal cancer odds ratios (ORs) and 95% confidence intervals in relation to indices of occupational exposure to asbestos 
and respirable crystalline silica, Males 
  ASBESTOS RESPIRABLE CRYSTALLINE SILICA  
Exposure 
Indicator 
Category Cases (%) Controls (%) Model 1a Model 2b Cases (%)  Controls (%) Model 1a Model 2c 
Ever 
exposure 
Never 927 (45) 2827 (45) 1.0 (ref) 1.0 (ref) 1220 (59) 4440 (71) 1.0 (ref) 1.0 (ref) 
Ever 1126 (55) 3426 (55) 1.3 (1.2-1.4) 1.1 (0.99-1.3) 833 (41) 1813 (29) 1.3 (1.2-1.5) 1.3 (1.1-1.5) 
Duration of 
exposure 
(years) 
None 927 (45) 2827 (45) 1.0 (ref) 1.0 (ref) 1220 (59) 4440 (71) 1.0 (ref) 1.0 (ref) 
<10 488 (24) 1885 (30) 1.2 (1.0-1.3) 1.1 (0.92-1.2) 269 (13) 657 (11) 1.3 (1.1-1.6) 1.2 (1.0-1.4) 
10-19 204 (10) 526 (8) 1.4 (1.2-1.7) 1.2 (0.94-1.4) 171 (8) 393 (6) 1.2 (1.0-1.5) 1.2 (0.98-1.5) 
 20-29 148 (7) 389 (6) 1.3 (1.1-1.6) 1.1 (0.84-1.3) 122 (6) 239 (4) 1.4 (1.1-1.8) 1.3 (1.0-1.7) 
  30+ 286 (14) 626 (10) 1.5 (1.2-1.7) 1.2 (1.0-1.4) 271 (13) 524 (8) 1.3 (1.1-1.6) 1.4 (1.2-1.7) 
P test for 
trend 
    0.06    <0.0001 
Excluding 
unexposed  
        0.39       0.13 
Cumulative 
exposured 
None 927 (45) 2827 (45) 1.0 (ref) 1.0 (ref) 1220 (59) 4440 (71) 1.0 (ref) 1.0 (ref) 
<50 %ile 404 (20) 1710 (27) 1.1 (0.98-1.3) 1.1 (0.91-1.3) 321 (16) 904 (15) 1.2 (1.1-1.4) 1.2 (1.0-1.4) 
 50-75 %ile 310 (15) 857 (14) 1.3 (1.1-1.6) 1.1 (0.93-1.3) 229 (11) 456 (7) 1.3 (1.1-1.6) 1.3 (1.1-1.6) 
 75-90 %ile 222 (11) 515 (8) 1.3 (1.1-1.6) 1.1 (0.88-1.3) 181 (9) 272 (4) 1.6 (1.3-1.9) 1.4 (1.1-1.8) 
  >90 %ile 190 (9) 344 (6) 1.7 (1.4-2.1) 1.3 (1.0-1.6) 102 (5) 181 (3) 1.4 (1.1-1.8) 1.3 (0.96-1.8) 
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P test for 
trend 
    0.04    0.0002 
Excluding 
unexposed  
        0.41       0.38 
a Adjusted for study, age         
b Adjusted for study, age, alcohol intake, tobacco smoking (pack–years and years since quitting)   
c Adjusted for study, age, alcohol intake, tobacco smoking (pack–years and years since quitting), and exposure to asbestos   
d Based on exposure distribution in male control participants (expressed in fibers (f)/ml–years for asbestos and mg/m3–
years for RCS; see Table 2)   
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Table 4. Laryngeal cancer odds ratios and 95% confidence intervals in relation to indices of occupational exposure to asbestos and 
respirable crystalline silica, Females 
 
    ASBESTOS RESPIRABLE CRYSTALLINE SILICA 
Exposure Indicator Category Cases (%) Controls (%) Model 1a Model 2b Cases (%) Controls (%) Model 1a Model 2c 
Ever Exposure 
Never 179 (88) 1457 (91) 1.0 (ref) 1.0 (ref) 165 (81) 1402 (87) 1.0 (ref) 1.0 (ref) 
Ever 24 (12) 147 (9) 1.5 (0.91-2.3) 1.1 (0.63-1.8) 38 (19) 202 (13) 1.1 (0.71-1.6) 1.3 (0.78-2.0) 
Duration (years)d 
None 179 (88) 1457 (91) 1.0 (ref) 1.0 (ref) 165 (81) 1402 (87) 1.0 (ref) 1.0 (ref) 
< 50 %ile 13 (6) 62 (3.9) 1.9 (1.0-3.7) 1.3 (0.66-2.6) 21 (10) 99 (6) 1.3 (0.77-2.2) 1.2 (0.65-2.1) 
≥ 50 %ile 11 (5) 85 (5) 1.1 (0.6-2.2) 0.85 (0.41-1.8) 17 (8) 103 (6) 0.87 (0.49-1.5) 1.3 (0.69-2.6) 
Cumulative 
exposuree 
None 179 (88) 1457 (91) 1.0 (ref) 1.0 (ref) 165 (81) 1402 (87) 1.0 (ref) 1.0 (ref) 
< 50 %ile 14 (7) 74 (5) 1.9 (1.0-3.4) 1.3 (0.66-2.5) 17 (8) 101 (6) 1.1 (0.60-1.9) 1.0 (0.53-1.9) 
≥ 50 %ile 10 (5) 73 (5) 1.1 (0.6-2.2) 0.83 (0.38-1.8) 21 (10) 101 (6) 1.1 (0.64-1.8) 1.5 (0.82-2.8) 
a Adjusted for study, age         
b Adjusted for study, age, alcohol intake, tobacco smoking (pack–years) 
c Adjusted for study, age, alcohol intake, tobacco smoking (pack–years), and exposure to asbestos 
d 50%ile cutoff: Asbestos: 5 years; Respirable crystalline silica (RCS): 13 years 
e Based on exposure distribution in female control participants (expressed in fibers (f)/ml–years for asbestos and mg/m3–years for RCS; see Table 2) 
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Table 5. Laryngeal cancer odds ratios and 95% confidence intervals in relation to indices of occupational exposure to Chromium-VI / Nickel and 
Chromium-VI, Males 
  CHROMIUM-VI–NICKEL CHROMIUM-VI  
Exposure 
Indicator 
 Category Cases (%)  
Controls 
(%) 
Model 1a Model 2b Cases (%) 
Controls 
(%) 
OR Model 1a OR Model 2b 
Ever exposure Never 1453 (77) 4933 (83) 1.0 (ref) 1.00 (ref) 1453 (90) 4933 (95) 1.0 (ref) 1.0 (ref) 
Ever 445 (24) 1035 (17) 1.3 (1.1-1.5) 1.2 (1.0-1.4) 155 (10) 285 (6) 1.5 (1.3-1.9) 1.4 (1.1-1.8) 
Duration of 
exposure (years)  
None 1453 (77) 4933 (83) 1.0 (ref) 1.00 (ref) 1453 (90) 4933 (95) 1.0 (ref) 1.0 (ref) 
<10 209 (11) 520 (9) 1.1 (0.94-1.4) 1.0 (0.82-1.2) 58 (4) 115 (2) 1.6 (1.1-2.2) 1.5 (1.0-2.2) 
10-19 86 (5) 198 (3) 1.3 (1.0-1.8) 1.3 (1.0-1.8) 37 (2) 63 (1) 1.6 (1.0-2.4) 1.3 (0.78-2.0) 
20-29 61 (3) 129 (2) 1.5 (1.1-2.1) 1.5 (1.1-2.2) 25 (2) 37 (1) 1.9 (1.1-3.2) 1.7 (0.95-3.1) 
30+ 89 (5) 188 (3) 1.5 (1.1-1.9) 1.2 (0.89-1.6) 35 (2) 70 (1) 1.3 (0.85-2.0) 1.2 (0.71-1.9) 
P test for trend     0.02    0.04 
Excluding 
unexposed  
        0.03       0.57 
Cumulative 
exposurec  
None 1453 (77) 4933 (83) 1.0 (ref) 1.0 (ref) 1453 (90) 4933 (95) 1.0 (ref) 1.0 (ref) 
<50 %ile 221 (12) 517 (9) 1.2 (0.96-1.4) 1.1 (0.87-1.3) 65 (4) 143 (3) 1.3 (0.93-1.7) 1.2 (0.82-1.6) 
50-75 %ile 111 (6) 260 (4) 1.4 (1.1-1.8) 1.3 (0.98-1.7) 37 (2) 72 (1) 1.3 (0.87-2.0) 1.4 (0.87-2.2) 
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>75 %ile 114 (6) 258 (4) 1.5 (1.1-1.9) 1.3 (0.97-1.7) 53 (3) 70 (1) 2.4 (1.7-3.5) 1.9 (1.2-3.0) 
P test for trend     0.02    0.0014 
Excluding 
unexposed  
        0.15       0.15 
a Adjusted for study, age    
      
b Adjusted for study, age, alcohol intake, tobacco smoking (pack–years and years since quitting), asbestos exposure   
c Based on exposure distribution in male control participants (expressed in 
mg/m3–years for Cr-VI and unit–years for Cr-VI–nickel; see Table 2) 
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